Epidemiology Practice Questions

Q: Using a seatbelt is an example of which level of prevention?

Secondary. ### Explanation The correct answer is **Secondary Prevention**. In the context of injury epidemiology, levels of prevention are categorized based on the timing of the intervention relative to the "event" (the crash) and the "injury." 1. **Why Secondary Prevention is Correct:** Secondary prevention aims to **reduce the severity** of a disease or injury once the event has already started. A seatbelt does not prevent the car accident (the event) from occurring; rather, it intervenes *during* the crash to minimize the impact and prevent serious injury or death. In injury control, interventions that reduce the severity of trauma during the "human-machine-environment" interaction are classified as secondary. 2. **Why Other Options are Incorrect:** * **Primary Prevention:** This aims to prevent the occurrence of the event entirely. In this context, primary prevention would be measures like traffic signals, speed limits, or anti-lock braking systems (ABS) that prevent the crash from happening. * **Tertiary Prevention:** This focuses on limiting disability and complications after the injury has occurred. Examples include emergency medical services (EMS), trauma surgery, and long-term physical therapy. * **Rehabilitation:** This is a component of tertiary prevention aimed at restoring the individual to their maximum functional capacity. ### High-Yield Pearls for NEET-PG: * **Haddon’s Matrix:** This is the standard framework for injury prevention. * **Pre-event (Primary):** Prevents the crash (e.g., sober driving). * **Event (Secondary):** Prevents injury during the crash (e.g., **Seatbelts, Airbags, Helmets**). * **Post-event (Tertiary):** Prevents death/disability after injury (e.g., Golden Hour care). * **Key Distinction:** If a measure stops the disease/event from starting, it is Primary. If it detects it early or reduces its immediate impact, it is Secondary.

Q: Bias can be eliminated by all except?

Multivariate analysis. ### Explanation The core of this question lies in distinguishing between **Bias** and **Confounding**. While often discussed together, they are handled differently in epidemiological studies. **1. Why Multivariate Analysis is the Correct Answer:** Multivariate analysis is a statistical tool used to control for **confounding variables**, not bias. Bias is a systematic error in the design, conduct, or analysis of a study that results in a mistaken estimate of an exposure's effect on the risk of disease. Once bias is introduced into a study, it cannot be "adjusted" or "removed" statistically during the analysis phase. In contrast, confounding can be managed during the analysis phase using multivariate models or stratification. **2. Analysis of Incorrect Options (Methods to Eliminate Bias):** * **Matching (Option A):** Used primarily in Case-Control studies to eliminate **selection bias** and control for known confounders by ensuring that the cases and controls are similar with respect to specific variables (e.g., age, sex). * **Blinding (Option B):** This is the gold standard for eliminating **measurement/observer bias**. By keeping the participant (single), investigator (double), or data analyst (triple) unaware of the group assignment, subjective prejudices are removed. * **Randomization (Option C):** Known as the "heart" of a Randomized Controlled Trial (RCT), it eliminates **selection bias** by ensuring every participant has an equal chance of being assigned to any group, thereby balancing both known and unknown confounders. **Clinical Pearls for NEET-PG:** * **Bias** must be prevented at the **design and data collection stage**. * **Confounding** can be managed at both the **design stage** (Matching, Randomization, Restriction) and the **analysis stage** (Multivariate analysis, Stratification). * **Recall Bias** is most common in Case-Control studies, while **Loss-to-follow-up (Attrition) Bias** is common in Cohort studies.

Q: Screening for a disease is an application of which of the following concepts?

Disease with lag time. ### Explanation **1. Why "Disease with lag time" is correct:** Screening is the process of identifying unrecognized diseases in apparently healthy individuals. For screening to be effective and ethically justifiable, a disease must have a **Lead Time** (often referred to here as lag time). This is the period between the early detection of a disease (by screening) and its usual time of clinical diagnosis. If a disease progresses too rapidly without a detectable preclinical phase, screening offers no benefit because there is no window of opportunity to intervene and alter the outcome. **2. Analysis of Incorrect Options:** * **A. Acute disease:** These typically have a rapid onset and short duration. There is usually no significant preclinical phase, making screening impractical. * **C. Communicable diseases:** While some communicable diseases (like HIV or TB) are screened, "communicability" is not the underlying epidemiological *requirement* for screening. Many non-communicable diseases (like Cervical Cancer) are the primary targets of screening programs. * **D. Low case fatality:** Screening is actually prioritized for diseases with **high morbidity or mortality** (high case fatality) where early intervention can significantly save lives or reduce disability. **3. NEET-PG High-Yield Pearls:** * **Iceberg Phenomenon:** Screening aims to uncover the "submerged portion" of the iceberg (pre-symptomatic cases). * **Wilson and Jungner Criteria:** The gold standard criteria for a screening program; it states the condition should be an important health problem with a recognizable latent stage. * **Lead Time Bias:** An error in survival analysis where screening appears to prolong survival simply because the disease was detected earlier, not because the patient lived longer from the biological onset. * **Yield:** The amount of previously undiagnosed disease estimated by the screening test.

Q: In a screening test for Carcinoma Breast, the sensitivity is 90% and specificity is 98%. What is the chance of a patient with Carcinoma breast to be detected negative in screening conducted in two consecutive years?

1/100. ### Explanation **1. Understanding the Correct Answer (C: 1/100)** The question asks for the probability of a patient with the disease being detected as **negative** (a False Negative) in two consecutive screening rounds. * **Sensitivity** is the ability of a test to correctly identify those with the disease. Here, Sensitivity = 90% (0.9). * **False Negative Rate (FNR)** is the probability that a person with the disease will test negative. It is calculated as: $1 - \text{Sensitivity}$. * $FNR = 1 - 0.9 = 0.1$ (or $1/10$). * **Consecutive Events:** Since the screenings in two different years are independent events, we use the **multiplication rule** of probability. * Probability of testing negative in Year 1 AND Year 2 = $FNR \times FNR$ * $1/10 \times 1/10 = \mathbf{1/100}$. **2. Analysis of Incorrect Options** * **Option A & B (1/10):** This represents the False Negative Rate for a **single** screening test. It fails to account for the second consecutive year. * **Option D (1/100):** While the numerical value is correct, in a standard MCQ format, only one specific option is designated as the key. (Note: In the provided prompt, C and D are identical; mathematically, 1/100 is the only correct derivation). **3. High-Yield Clinical Pearls for NEET-PG** * **Sensitivity (True Positive Rate):** High sensitivity is required for **screening tests** to ensure fewer cases are missed (low False Negatives). * **Specificity (True Negative Rate):** High specificity is required for **confirmatory tests** to avoid unnecessary treatment (low False Positives). * **Relationship:** * False Negative Rate = $1 - \text{Sensitivity}$ (Type II Error / $\beta$) * False Positive Rate = $1 - \text{Specificity}$ (Type I Error / $\alpha$) * **Screening Interval:** Repeated screening (serial testing) increases the "Net Sensitivity" but decreases the "Net Specificity" of the diagnostic process.

Q: Which of the following statements is NOT true about the term 'disease control'?

Interruption of the transmission of disease. ### Explanation In epidemiology, it is crucial to distinguish between disease **control**, **elimination**, and **eradication**. **Why Option A is the Correct Answer (The "Not True" Statement):** **Interruption of the transmission of disease** is the defining characteristic of **Elimination**, not control. In the control phase, the disease continues to transmit within the community, but at a level that is no longer considered a significant public health problem. Elimination refers to achieving "zero incidence" in a specific geographic area (e.g., Polio elimination in India), whereas control is merely the reduction of the disease burden. **Analysis of Other Options:** * **Option B (Reducing incidence):** This is a primary objective of disease control. It aims to reduce the number of new cases (incidence), the total number of existing cases (prevalence), and the associated morbidity/mortality. * **Option C (Agent persists at low levels):** In the control stage, the infectious agent is still present in the environment or population. It is not wiped out; it is simply managed. * **Option D (Focus on prevention):** Disease control relies heavily on **Primary prevention** (e.g., immunization, health promotion) to reduce incidence and **Secondary prevention** (e.g., early diagnosis and treatment) to reduce prevalence and transmission. **High-Yield Clinical Pearls for NEET-PG:** * **Control:** Reduction in incidence, prevalence, morbidity, or mortality to locally acceptable levels. * **Elimination:** Interruption of transmission (zero incidence) in a **defined geographic area** (e.g., Neonatal Tetanus). * **Eradication:** Permanent reduction to **zero worldwide**; the agent is completely extinct in nature (e.g., Smallpox, 1980). * **Monitoring:** The continuous performance and analysis of routine measurements. * **Surveillance:** Continuous scrutiny of all aspects of occurrence and spread of a disease.

Q: A group of smokers was followed up for 10 years to determine the incidence of lung cancer. What type of study is this?

Prospective cohort. ### Explanation **Correct Answer: B. Prospective Cohort** The study described is a **Prospective Cohort study** because it begins with a group of individuals (the cohort) who are currently free of the disease but differ in their exposure status (smokers). These individuals are followed forward in time (**longitudinal follow-up**) to observe the development of the outcome (lung cancer). In epidemiology, the hallmark of a cohort study is the direction of inquiry: **from Cause (Exposure) to Effect (Outcome).** Since the follow-up occurs from the present into the future, it is "prospective." --- ### Why other options are incorrect: * **A. Retrospective Cohort:** While this also moves from exposure to outcome, it uses past records (e.g., employment files from 1990) to determine exposure and looks at outcomes that have already occurred by the time the study starts. * **C. Case-Control Study:** This study design moves backward from **Effect to Cause**. It starts with people who already have lung cancer (cases) and compares them to those who don't (controls) to look for past smoking habits. * **D. Randomized Control Trial (RCT):** This is an experimental study where the investigator intervenes (e.g., gives a drug). In the question, the investigator is merely observing natural behavior (smoking), making it an observational study, not a trial. --- ### NEET-PG High-Yield Pearls: * **Incidence:** Cohort studies are the only observational studies that can directly calculate the **Incidence** of a disease. * **Risk Measure:** The primary measure of association in a cohort study is **Relative Risk (RR)** or Risk Ratio. * **Best for Rare Exposures:** Cohort studies are ideal for studying rare exposures (e.g., a specific chemical in a factory), whereas Case-Control studies are best for rare diseases. * **Mnemonic:** **C**ohort = **C**ause to Effect; **C**ase-Control = **C**onsequence to Cause.

Question 1

Using a seatbelt is an example of which level of prevention?

Accepted Answer

Secondary

Answer

Primary

Answer

Tertiary

Answer

Rehabilitation

Question 2

Bias can be eliminated by all except?

Accepted Answer

Multivariate analysis

Answer

Matching

Answer

Blinding

Answer

Randomization

Question 3

Screening for a disease is an application of which of the following concepts?

Accepted Answer

Disease with lag time

Answer

Acute disease

Answer

Communicable diseases

Answer

Low case fatality

Question 4

What is the major purpose of randomization in a clinical trial?

Accepted Answer

To reduce selection bias in allocation of treatment

Answer

To facilitate double blinding

Answer

To help ensure the study subjects are representative of the general population

Answer

To ensure the groups are comparable in baseline characteristics

Question 5

In a screening test for Carcinoma Breast, the sensitivity is 90% and specificity is 98%. What is the chance of a patient with Carcinoma breast to be detected negative in screening conducted in two consecutive years?

Accepted Answer

1/100

Answer

1/10

Answer

1/10

Question 6

What is the best level of prevention for Breast cancer?

Accepted Answer

Early diagnosis and treatment

Answer

Specific protection

Answer

Disability limitation

Answer

Rehabilitation

Question 7

Which of the following indicators is NOT included in the Human Development Index (HDI)?

Accepted Answer

Life expectancy at age 1

Answer

Mean years of schooling

Answer

Real GDP per capita

Answer

Adult literacy rate

Question 8

Which of the following statements is NOT true about the term 'disease control'?

Accepted Answer

Interruption of the transmission of disease

Answer

Reducing the incidence of disease

Answer

Agent is permitted to persist at low levels

Answer

Focus is on primary and/or secondary prevention

Question 9

Regarding the epidemiology of AIDS, all the following statements are true EXCEPT:

Accepted Answer

Maternofetal transmission is the most common mode of transmission.

Answer

In India, AIDS is mainly caused by HIV-1.

Answer

Intravenous drug abuse increases the risk of transmission.

Answer

Medical personnel are at higher risk of acquiring HIV infection.

Question 10

A group of smokers was followed up for 10 years to determine the incidence of lung cancer. What type of study is this?

Accepted Answer

Prospective cohort

Answer

Retrospective cohort

Answer

Case control study

Answer

Randomized control trial

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?